Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
Thrombomodulin (THBD) is a type I single-pass transmembrane glycoprotein encoded by the THBD gene, selectively expressed on luminal plasma membranes of vascular endothelial cell populations across circulatory compartments. The polypeptide architecture consists of a lengthy heavily glycosylated extracellular multi-repeat domain, one single hydrophobic transmembrane anchor and a short cytoplasmic terminal segment lacking intrinsic enzymatic catalytic motifs. Structural characterization confirms the extracellular domain forms multi-step non-covalent binding interfaces with circulating serine protease substrates and regulatory cofactors, forming membrane-tethered molecular complexes that adjust the catalytic output of blood protease cascades. Unrestrained protease activation within vascular lumens tends to disrupt circulatory steady state without intact THBD surface assemblies, and graded THBD surface density creates a tissue-wide buffering system to restrain excessive protease catalytic activity under basal physiological flow conditions. Different vessel diameter segments adjust THBD membrane abundance to match local fluid shear and protease exposure levels; sequential extracellular repeat units carry distinct binding pockets that coordinate ordered assembly of multi-molecular regulatory complexes at endothelial cell surfaces. Conserved disulfide linkages within each extracellular repeat fold stabilize ligand-binding pocket geometry to sustain weak, reversible protease-cofactor coordination interactions.
Sequence variants within THBD extracellular repeat regions might disrupt disulfide bond arrangement and alter protease cofactor binding affinity, which could shift circulatory cascade equilibrium in vascular tissue model systems. No other endothelial transmembrane glycoprotein replicates THBD’s sequential multi-repeat binding architecture for protease regulatory complexes, though isolated single-domain binding activity exists among unrelated surface factors. THBD stably integrates into endothelial lipid bilayers and does not shed into free soluble pools under standard basal flow conditions. Its type I membrane topology separates extracellular regulatory folds from short cytoplasmic tails, granting dual functional potential: luminal protease cascade modulation and weak cytoplasmic signal relay upon multi-molecular complex assembly. Reduced THBD surface abundance weakens endothelial protease buffering capacity, allowing unbalanced circulatory cascade activation within vessel lumens, making this endothelial glycoprotein a suitable research target for vascular homeostatic regulation analysis.
Fig. 1 Domain topology of CTLD group‑14 transmembrane protein family, highlighting THBD with its characteristic extracellular modular architecture, single‑pass transmembrane segment and short cytoplasmic tail.1
The biological functions of integral membrane THBD endothelial glycoprotein are focused on luminal protease complex assembly and circulatory cascade attenuation:
Creative Biolabs offers purified THBD membrane protein samples produced under unified preparation workflows, including full-length THBD constructs and isolated extracellular repeat domain variants. Truncated fragments cannot support complete multi-component protease complex assembly activity, while full-length forms fit vascular endothelial research. All batches receive uniform quality screening. Functional assessments may only be performed under simulated lipid bilayer microenvironment setups. Tandem repeat disulfide fold structural features are preserved across batches to support comparative protease co-binding analysis between experimental groups. Full-length THBD membrane samples retain intact ligand coordination pockets post-purification, supporting reliable detection of transient multi-molecular protease complexes in comparative functional analysis.
Not finding the Membrane Protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides cell research models with adjustable THBD expression levels, suitable for structural observation of endothelial type I transmembrane glycoproteins and vascular cascade research. Sample assessment covers sustained luminal membrane detection and protease co-binding analysis, enabling side-by-side comparison of cascade buffering capacity under varying THBD abundances. These cell models can be paired with circulatory protease quantification schemes to track catalytic activity shifts linked to THBD dosage changes.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-THBD recombinant antibodies are generated via standardized workflows, compatible with endothelial luminal membrane localization mapping and protease complex identification. The antibody series supports multi-dimensional observation of THBD distribution within vessel wall tissue samples.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for THBD research:
THBD may act as type I transmembrane endothelial glycoprotein to assemble luminal protease-cofactor complexes and restrain unbalanced circulatory cascade activity.
THBD surface abundance might modulate vessel luminal protease equilibrium, serving as a key mediator of vascular tissue homeostasis biological processes.
No, all THBD related products and services are strictly for research use only, and cannot be applied in clinical workflows. All material design and functional screening are optimized exclusively for basic laboratory research, without meeting clinical application criteria.
Offerings include full-length THBD membrane protein, target-specific recombinant antibodies and tunable expression cell research models, supporting research on endothelial protease regulation.
Laboratory analysis schemes may include protease cofactor co-binding assays to assess multi-molecular complex formation capacity under simulated lipid bilayer environments.
